Our team is engaged in interdisciplinary studies focused on creating innovative materials and approaches for combating infectious diseases. We utilize bio-derived substances, repurposed agents, and nanotechnology-based materials in our research, which encompasses various related subjects:

• Bacterial small noncoding RNAs (sRNAs): Functions and mechanism of action (MOA) 

• Extracellular vesicles (EVs): Understanding biogenesis pathways and their genetic components using multiomics studies and their utilization in the development of novel vaccine and antibacterial platforms

• Nanoantibiotics: Development of biocompatible and stimuli-responsive nanoantibiotic platforms

• Synergistic antibiotics: Identification of novel synergistic materials to antibiotics and their mechanism of action

• Ribonucleases and their inhibitors: Discovery of trans-acting regulators of ribonucleases and their mechanisms

• Nano-based Drug-delivery vehicle: New development of nano-drug-delivery vehicles for biomedical applications